Glialign was established in 2018 to take forward the work of UCL academics in engineering live neural tissue. Their current project has been funded by the UCL Technology Fund, UK Innovation and Science: Seed Fund (UKI2S) and Innovate UK. The founders James Phillips and John Sinden are currently optimising a method for producing a living nerve growth guide designated “EngNT”, which is intended as an ‘off-the-shelf’ nerve replacement – primarily for peripheral nerve repair. This represents an innovative engineering solution to an unmet clinical need.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology

Associated Team Members

More Companies in Medical / Biotechnology

Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now